Staff

Lead researchers

Professor Robert Read

Chair of Infectious Diseases
Connect with Robert

Email: R.C.Read@soton.ac.uk

Other researchers

Professor Chris Byrne

Professor of Endocrinol & Met
Connect with Chris

Email: C.D.Byrne@soton.ac.uk

Professor Cyrus Cooper

Prof Rheumatology Clinical Epidemiology
Research interests
  • Key research contributions have been:
  • discovery of the developmental influences which contribute to the risk of osteoporosis and hi…
  • demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone miner…
Connect with Cyrus

Email: cc@mrc.soton.ac.uk

Professor Philip Calder

Professor In Nutritional Immunology
Connect with Philip

Email: P.C.Calder@soton.ac.uk

Professor Ratko Djukanovic

Professor of Medicine
Research interests
  • Professor Djukanovic has a lifelong interest in asthma, especially its severe forms. where hi…
  • Underlying mechanisms of asthma: Professor Djukanovic has conducted pioneer studies into the …
  • Stratification of asthma into clinical phenotypes and mechanism-based endotypes: Professor Dj…
Connect with Ratko

Email: rd1@soton.ac.uk

Professor Keith Godfrey

Associate Dean Enterprise
Connect with Keith

Email: kmg@mrc.soton.ac.uk

Professor Hasan Arshad

Prof in Allergy & Clinical Immunology
Connect with Hasan

Email: S.H.Arshad@soton.ac.uk

Dr Stephen Wootton PhD FAfN OBE

Associate Professor
Connect with Stephen

Email: S.A.Wootton@soton.ac.uk

Professor Graham Roberts

Prof in Paed. Allergy & Resp. Medicine
Connect with Graham

Email: g.c.roberts@soton.ac.uk

Professor Saul Faust MBBS, PhD, FRCPCH, FFPM(Hon), FHEA, OBE

Professor Paediatric Immunology & Infect
Connect with Saul

Email: s.faust@soton.ac.uk

Research outputs

Adaptation of the INTERGROWTH-21st neurodevelopment assessment (INTER-NDA) to the context of the English-speaking Caribbean
2022, BMC Pediatrics, 22
DOI: 10.1186/s12887-021-03039-7
Type: article
Deleterious genetic variation across the NOD-signaling pathway is associated with reduced NFKB-signaling transcription and upregulation of alternative inflammatory transcripts in paediatric inflammatory bowel disease
James Ashton, Konstantinos Boukas, Imogen, Sian Stafford, Guo Cheng, Rachel Haggarty, Tracy Coelho, Akshay Batra, Nadeem A. Afzal, Anthony Williams, Marta Polak, R. Mark Beattie & Sarah Ennis, 2022, Inflammatory Bowel Diseases, 28(6), 912-922
DOI: 10.1093/ibd/izab318
Type: article
Editorial: Keeping the body in mind: scientific effort in advocating the best outcomes for people living with severe mental illness
Katherine Samaras, David Shiers, Roger Chen, Richard I.G. Holt & Jackie Curtis, 2022, Frontiers in Endocrinology, 12
DOI: 10.3389/fendo.2021.831933
Type: letterEditorial
Multi-excitation Raman spectroscopy for label-free, strain-level characterization of bacterial pathogens in artificial sputum media
Jeremy Webb, Adam Lister, Callum Highmore, Niall Hanrahan, James, Arthur Read, Alasdair, Peter Stuart Munro, Samuel Tan, Raymond Allan, Saul Faust & Sumeet Mahajan, 2022, Analytical Chemistry, 94(2), 669-677
DOI: 10.1021/acs.analchem.1c02501
Type: article
A novel quantitative ultrasound technique for identifying nonalcoholic steatohepatitis
Feng Gao, Qiong He, Gang Li, Ou-Yang Huang , Liang-Jie Tang, Xiao-Dong Wang, Giovanni Targher , Christopher Byrne, Jian-Wen Luo & Ming-Hua Zheng, 2022, Liver International, 42(1), 80-91
DOI: 10.1111/liv.15064
Type: article
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus , HE Mark, QM Anstee, JP Arab , RL Batterham , L Castera , H Cortez-Pinto , J Crespo , K Cusi , MA Dirac, S Francque , J George , H Hagström , TT Huang , MH Ismail , A Kautz, SK Sarin, R Loomba , V Miller , PN Newsome , M Ninburg , P Ocama , V Ratziu , M Rinella , D Romero , M Romero-Gómez, JM Schattenberg , EA Tsochatzis , L Valenti, VW Wong , Y Yilmaz, ZM Younossi , S Zelber-Sagi , NAFLD Consensus Consortium & Christopher Byrne, 2022, Nature Reviews Gastroenterology & Hepatology, 19(1), 60-78
DOI: 10.1038/s41575-021-00523-4
Type: review
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Nick J Andrews, J C Cameron, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins, Tom Darton, Tanya Dinesh, Christopher J A Duncan, Anna England, Saul N Faust, Daniela M Ferreira, Adam Finn, Anna L Goodman, Christopher A Green, Bassam Hallis, Paul T Heath, Helen Hill, Bryn M Horsington, Teresa Lambe, Rajeka Lazarus, Vincenzo Libri, Patrick J Lillie, Yama F Mujadidi, Ruth Payne, Emma L Plested, Samuel Provstgaard-Morys, Maheshi N Ramasamy, Mary Ramsay, Robert C Read, Hannah Robinson, Gavin R Screaton, Nisha Singh, David P J Turner, Paul J Turner, Iason Vichos, Rachel White, Jonathan S Nguyen-Van-Tam & Matthew D Snape, 2022, The Lancet, 399(10319), 36-49
DOI: 10.1016/S0140-6736(21)02718-5
Type: article